September 25, 2013 | Lucid, Strategic planning, medical education
Written by Jan Steele PhD, operations director, Lucid
In this era of change, where we often focus on ‘new stakeholders’, the art and science of working with medical experts and ensuring that your relationship is productive for both parties is often neglected. However, there is still an important place for knowing your experts and working with them on carefully chosen projects to ensure a strong partnership.
Why work with experts?
Essentially, medical experts will lead change. For example, it will be these experts who will discuss the appropriate and effective use of new medicines. Similarly, when there are new data in a therapeutic area, it will be the experts who interpret the data and explain to other healthcare professionals what these data mean for their clinical practice.
What’s more, experts hold the key to effective working: they are the people who can help you have really good insight into the diseases you are treating and the medicines you are developing/commercialising.
For many of the experts, working with pharma not only provides a welcome diversion from their daily routines, but pharma is increasingly seen as an important partner for new trials, important disease awareness campaigns and scientific exchange. Companies who want to be known for scientific leadership should have working with experts as their top priority.
What do experts say about working with pharma?
In a recent survey of how experts felt about working with pharma, the average score was 4.5/10. The main reasons for this low score were:
So, clearly there is room for improvement!
How to work with experts
Although not rocket science, we believe a carefully crafted process, adopted by all the team responsible for working with experts, enhances the experience for all parties.
We propose a five-stage process to help clients work more effectively with their experts, advancing partnership.
ADVANCE partnership process
1. Identify and understand your experts
Desk research of professional societies, publications’ databases and recent meetings will yield a good list of experts who are important and/or active in the field. However, the list gives you a very one dimensional picture.
Our ADVANCE partnership methodology has an extra step: where we find out how each expert exerts his influence on his peers and we understand how each expert likes to work with pharma, his passion for science and enthusiasm for innovation.
2. Engage your experts fully in your plans
Once you have understood your group of experts, you can identify a core team who will be motivated to work with you on your strategic goals. It is critical at this stage of your planning to ENGAGE the experts, and work with them to form your plans.
3. Programme development: ensure an alignment between your objectives and clinical needs and questions
By discussing the major questions that experts (and other HCPs) have in the area and by asking about the clinical hot topics and how your brand fits, programmes that add value to your brand and to the medical community will be devised.
4. Right expert, right job!
If you have understood your team of experts well, and engaged it in the development of your plans, aligning the right expert to the right programme will be straightforward.
5. Transparent plans and contracts
In this era of increased scrutiny of both pharma and experts’ relationships with pharma, it is critical to agree and update a plan or contract with each expert in your team at least annually.
In summary, working with experts well is not rocket science, but all the steps in the ADVANCE expert alignment model must be followed. This ensures the work you do profits not only you, but the experts and the wider medical community. And it also supports you to advance your partnership with your experts, and this is critical, as you need their support and guidance to help you effect change.
For more information click here: http://www.lucid-group.net/
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
What do you think of when you imagine a scientist? Who do you see in a lab coat? Gender stereotypes and assumptions are rife and, as a child, the thought...
Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. On this day across the globe, the rare...
We are extending the conversation for Rare Disease Day by continuing to raise awareness and generate change for the 300 million people worldwide living with a rare disease, their families...
We interviewed Paul Cutler, Lucid Group’s new Chief People Officer, to find out a bit more about what makes him tick, why he chose to join Lucid, and what his...
The newly formed Lucid Social Committee is launching its first event for the year: Today, on Thursday 24 February Lucid will be hosting its inaugural board games night in both...
We are excited to welcome this year’s cohort of graduates into our Lucid Futures Academy, which is now into its sixth year after being launched in Oct 2017.The Futures Academy...
People are at the heart of who we are. Our aim is to transform the lives of those we touch without prejudice or discrimination. At Lucid, the magic we create...
Transforming lives. That’s what Lucid is all about. I knew that even before I stepped through the fabled door of ‘Towers’ on a chilly January morning in 2019. It’s why...
Last week’s ‘Thirsty Thursday’ session was organised by the Lucid Group D&I Committee, whose goal is to foster a culture where diversity and inclusivity are embedded and practised within all...
The account management/medical writing paradigm was the cornerstone of medcomms for many years, but evolution in technology, storytelling and an increasingly sophisticated audience has changed this.Instead, today's environment requires an integrated,...